Condition
Gastroesophageal Varices Hemorrhage
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Unknown4
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07502729Not Yet Recruiting
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding
NCT05891184UnknownPrimary
Color Doppler US and TE as Predictors for Presence of Gastroesophageal Varices and Variceal Bleeding in Patients With LC
NCT05141617Not ApplicableUnknownPrimary
Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding
NCT04524676Not ApplicableUnknownPrimary
Oxaliplatin-induced Portal Hypertension
NCT01451658Phase 4UnknownPrimary
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)
Showing all 5 trials